Citation Impact
Citing Papers
Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery
2007 Standout
Species Interactions in a Parasite Community Drive Infection Risk in a Wildlife Population
2010 StandoutScience
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
2018 Standout
Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia
2013
Heparin-Protein Interactions
2002 Standout
Incidence and clinical significance of anti‐PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin‐induced thrombocytopenia
2006
Manipulation of cell surface macromolecules by flaviviruses
2003
Cellular microparticles: new players in the field of vascular disease?
2004
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Approach to the Diagnosis and Management of Drug-Induced Immune Thrombocytopenia
2013
Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex
2001 StandoutNobel
Regulation of cell death: the calcium–apoptosis link
2003 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Laboratory Testing for Heparin-Induced Thrombocytopenia
2000
The Complete Genome Sequence of Shope (Rabbit) Fibroma Virus
1999
An Improved Definition of Immune Heparin-Induced Thrombocytopenia in Postoperative Orthopedic Patients
2003
Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention
2004
Heparin-Induced thrombocytopenia: IgG-Mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-Induced thrombocytopenia
1996
Heparin-Induced Thrombocytopenia
1998
Argatroban Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
2003
Antiphospholipid Syndrome and Heparin-induced Thrombocytopenia: Update on Similarities and Differences
2000
Temporal Aspects of Heparin-Induced Thrombocytopenia
2001 Standout
Indications for Blood Transfusion in Cardiac Surgery
2006
Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia
1999
Thrombin signalling and protease-activated receptors
2000 StandoutNature
Antithrombotic Therapy for VTE Disease
2012 Standout
Photolyase/cryptochrome blue-light photoreceptors use photon energy to repair DNA and reset the circadian clock
2002 StandoutNobel
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis
2005
Integrin-mediated signal transduction
1998
Heparin-Induced Thrombocytopenia
2006 Standout
The Antiphospholipid Syndrome
2002 Standout
Signal transduction by lymphocyte antigen receptors
1994 Standout
Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation
2005
HEPARIN-INDUCED THROMBOCYTOPENIA, PARADOXICAL THROMBOEMBOLISM, AND OTHER SIDE EFFECTS OF HEPARIN THERAPY
1998
Prevention of Venous Thromboembolism
2004 Standout
Heparin and Low-Molecular-Weight Heparin
1998
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
1999 Standout
Poxvirus tropism
2005
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2012
Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy
2000
Vaccinia virus immune evasion
1997
Co-localization of CD9 and GPIIb-IIIa (·IIb ·3 integrin) on activated platelet pseudopods and ·-granule membranes
1997
A 14-year study of heparin-induced thrombocytopenia
1996 Standout
Safety of Warfarin Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
1999
The CD19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B lymphocytes
1993
The Pathophysiology of Heparin-Induced Thrombocytopenia
2005
Disseminated Intravascular Coagulation
1999 Standout
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
2001 Standout
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
1997 Standout
Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia
1999
Recurrent miscarriage
2006 Standout
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
2011 Standout
Heparin-induced Thrombocytopenia, a Prothrombotic Disease
2007
Complications of Femoral and Subclavian Venous Catheterization in Critically Ill Patients<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001 Standout
Extracellular vesicles: biology and emerging therapeutic opportunities
2013 Standout
Alterations in Bcl‐2/Bax protein levels in platelets form part of an ionomycin‐induced process that resembles apoptosis
1997
Negative regulation of activation-induced cytidine deaminase in B cells
2006 StandoutNobel
Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis
2001
The Genome of Swinepox Virus
2002
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy.
1998
Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range
2000
Characterization and functional analysis of Serp3: a novel myxoma virus-encoded serpin involved in virulence
2001
Serpin Structure, Mechanism, and Function
2002 Standout
Myxoma Virus M11L Prevents Apoptosis through Constitutive Interaction with Bak
2004
Heparin-induced Thrombocytopenia: Towards Consensus
1998
Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studies
2004
Recombinant Hirudin (Lepirudin) Provides Safe and Effective Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
1999
Viruses and Apoptosis
1999
Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor.
1995 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
State-of-the-Art Review : Heparin-induced Thrombocytopenia and Thrombosis Syndrome
1998
Vaccinia Virus Inhibits the Maturation of Human Dendritic Cells: A Novel Mechanism of Immune Evasion
1999 StandoutNobel
FcγRIIA H/R131 Polymorphism, Subclass-Specific IgG Anti-Heparin/Platelet Factor 4 Antibodies and Clinical Course in Patients With Heparin-Induced Thrombocytopenia and Thrombosis
1997
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and -Granules
1999 Standout
Clustering of the platelet Fc gamma receptor induces noncovalent association with the tyrosine kinase p72syk.
1994
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Circulating Procoagulant Microparticles in Women with Unexplained Pregnancy Loss: a New Insight
2001
The Genome of Fowlpox Virus
2000
Alteration of Marrow Cell Gene Expression, Protein Production, and Engraftment into Lung by Lung-Derived Microvesicles: A Novel Mechanism for Phenotype Modulation
2007
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Viral Subversion of the Immune System
2000
Poxviruses and Immune Evasion
2003
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
2021 Standout
Low-Molecular-Weight Heparins
1997 Standout
Cell-Derived Microparticles Generated in Patients During Cardiopulmonary Bypass Are Highly Procoagulant
1997
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
2014 Standout
Management of Deep Vein Thrombosis and Pulmonary Embolism
1996
Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range
2000
M062 Is a Host Range Factor Essential for Myxoma Virus Pathogenesis and Functions as an Antagonist of Host SAMD9 in Human Cells
2011
The tetraspanin superfamily: molecular facilitators
1997
Structure and function of the human platelet thrombin receptor. Studies using monoclonal antibodies directed against a defined domain within the receptor N terminus.
1992
Lepirudin (Recombinant Hirudin) for Parenteral Anticoagulation in Patients With Heparin-Induced Thrombocytopenia
1999
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
2003 StandoutNobel
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
2021 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
2001 Standout
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
2004 Standout
Cellular origin and procoagulant properties of microparticles in meningococcal sepsis
2000
Generation of platelet-derived microparticles and procoagulant activity by heparin-induced thrombocytopenia IgG/serum and other IgG platelet agonists: a comparison with standard platelet agonists
1999
C7L Family of Poxvirus Host Range Genes Inhibits Antiviral Activities Induced by Type I Interferons and Interferon Regulatory Factor 1
2012 StandoutNobel
Endothelial Function and Dysfunction
2007 Standout
Works of L Boshkov being referenced
Hypotension and acute pulmonary insufficiency following transfusion of autologous red blood cells during surgery: a case report and review of the literature
2004
Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia
1994
Platelet activation by immobilized monoclonal antibody: evidence for a CD9 proximal signal
1991
Myxoma virus induces extensive CD4 downregulation and dissociation of p56lck in infected rabbit CD4+ T lymphocytes
1995
Virus-induced loss of class I MHC antigens from the surface of cells infected with myxoma virus and malignant rabbit fibroma virus
1992
Disruption of M-T5, a novel myxoma virus gene member of poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits
1996